Regulus Therapeutics Inc. (RGLS) Retained Earnings (Accumulated Deficit) USD 2011 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
Regulus Therapeutics Inc. quarterly Retained Earnings (Accumulated Deficit) history and growth rate from 2011 to 2024.
  • Regulus Therapeutics Inc. Retained Earnings (Accumulated Deficit) for the quarter ending March 31, 2024 was -$522 M, a 6.4% decline year-over-year.
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 -$522 M -$31.4 M -6.4% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$513 M -$30 M -6.22% Dec 31, 2023 10-Q 2024-05-09
Q3 2023 -$505 M -$28.8 M -6.04% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 -$497 M -$28.5 M -6.08% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 -$490 M -$28.7 M -6.23% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 -$483 M -$28.3 M -6.23% Dec 31, 2022 10-K 2024-03-21
Q3 2022 -$476 M -$28.7 M -6.4% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 -$469 M -$29.7 M -6.77% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 -$462 M -$28.5 M -6.58% Mar 31, 2022 10-Q 2022-05-13
Q4 2021 -$455 M -$27.8 M -6.51% Dec 31, 2021 10-K 2023-03-23
Q3 2021 -$448 M -$22 M -5.17% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 -$439 M -$14.9 M -3.51% Jun 30, 2021 10-Q 2021-08-10
Q1 2021 -$433 M -$15.8 M -3.79% Mar 31, 2021 10-Q 2021-05-14
Q4 2020 -$427 M -$15.7 M -3.82% Dec 31, 2020 10-K 2022-03-11
Q3 2020 -$426 M -$19.3 M -4.75% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 -$424 M -$23.2 M -5.79% Jun 30, 2020 10-Q 2020-08-13
Q1 2020 -$417 M -$21.3 M -5.37% Mar 31, 2020 10-Q 2020-05-14
Q4 2019 -$411 M -$18.6 M -4.73% Dec 31, 2019 10-K 2021-03-09
Q3 2019 -$406 M -$22.3 M -5.8% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 -$401 M -$27.1 M -7.25% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 -$396 M -$35.9 M -9.98% Mar 31, 2019 10-Q 2019-05-10
Q4 2018 -$393 M -$46.9 M -13.6% Dec 31, 2018 10-K 2020-03-12
Q3 2018 -$384 M -$52.8 M -15.9% Sep 30, 2018 10-Q 2018-11-09
Q2 2018 -$374 M -$58.3 M -18.5% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 -$360 M -$66.1 M -22.5% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 -$346 M -$72.5 M -26.5% Dec 31, 2017 10-K 2019-03-18
Q3 2017 -$331 M -$78.1 M -30.8% Sep 30, 2017 10-Q 2017-11-08
Q2 2017 -$316 M -$81.8 M -35% Jun 30, 2017 10-Q 2017-08-02
Q1 2017 -$294 M -$81.3 M -38.2% Mar 31, 2017 10-Q 2017-05-05
Q4 2016 -$273 M -$81.8 M -42.7% Dec 31, 2016 10-K 2018-03-08
Q3 2016 -$253 M -$69 M -37.5% Sep 30, 2016 10-Q 2016-11-02
Q2 2016 -$234 M -$62.5 M -36.5% Jun 30, 2016 10-Q 2016-08-03
Q1 2016 -$213 M -$62.5 M -41.6% Mar 31, 2016 10-Q 2016-05-03
Q4 2015 -$192 M -$55.7 M -41.1% Dec 31, 2015 10-K 2017-03-03
Q3 2015 -$184 M -$70.7 M -62.2% Sep 30, 2015 10-Q 2015-11-06
Q2 2015 -$171 M -$67.5 M -65% Jun 30, 2015 10-Q 2015-08-05
Q1 2015 -$150 M -$58.4 M -63.6% Mar 31, 2015 10-Q 2015-05-08
Q4 2014 -$136 M -$56.7 M -71.7% Dec 31, 2014 10-K 2016-02-23
Q3 2014 -$114 M -$36.4 M -47.2% Sep 30, 2014 10-Q 2014-11-06
Q2 2014 -$104 M -$28.8 M -38.4% Jun 30, 2014 10-Q 2014-08-07
Q1 2014 -$91.8 M -$24.2 M -35.7% Mar 31, 2014 10-Q 2014-05-09
Q4 2013 -$79.1 M -$18.7 M -30.9% Dec 31, 2013 10-K 2015-02-19
Q3 2013 -$77.2 M -$23.6 M -44.1% Sep 30, 2013 10-Q 2013-11-14
Q2 2013 -$75 M Jun 30, 2013 10-Q/A 2013-08-16
Q1 2013 -$67.6 M Mar 31, 2013 10-Q 2013-05-15
Q4 2012 -$60.4 M -$17.4 M -40.5% Dec 31, 2012 10-K 2014-02-28
Q3 2012 -$53.5 M Sep 30, 2012 10-Q 2012-11-19
Q4 2011 -$43 M Dec 31, 2011 10-K 2013-02-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.